Patients with heart failure who require an implantable defibrillator should have cardiac resynchronisation routinely

Heart

Volumn 94, Issue 8, 2008, Pages 963-966

  Cleland, John G F ^a   Tageldien, Ahmed ^a   Maarouf, Nidal ^a   Hobson, Neil ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; METOPROLOL SUCCINATE; PLACEBO; SPIRONOLACTONE;

AMBULATORY MONITORING; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; DEFIBRILLATION; DEFIBRILLATOR; DEVICE INFECTION; DEVICE THERAPY; DISEASE EXACERBATION; EDITORIAL; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; EXERCISE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART PACING; HEART VENTRICLE TACHYCARDIA; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QRS COMPLEX; QUALITY OF LIFE; RISK ASSESSMENT; SUDDEN DEATH;

CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; EVIDENCE-BASED MEDICINE; HEART FAILURE; HUMANS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 47849121248     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2008.143594     Document Type: Editorial

References (26)

1. National Institute for Health and Clinical Excellence. http://www.nice.org.uk/ 2008.
2. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
3. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
4. Cleland JGF, Ghosh J, Freemantle N, et al. Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-LIPIDS and cardiac resynchronisation therapy in heart failure. Eur J Heart Fail 2004;6:501-8.
5. Teerlink JR, Jalaluddin M, Anderson S, et al. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. Circulation 2000;101:40-6.
6. Nolan J, Batin PD, Andrews R, et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 1998;98:1510-6.
7. Cleland JGF, Goode K. Natriuretic peptides for heart failure. Fashionable? Useful? Necessary? Eur J Heart Failure 2004;6:253-5.
8. Morgan JM, Cowan JC, Camm AJ, et al. Sudden cardiac death: opportunities for prevention. Heart 2006;b:721-3.
9. Khan NK, Goode KM, Cleland JGF, et al. Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge. Eur J Heart Fail 2007;9:491-501.
10. Anderson KP. Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government. J Interven Card Electrophysiol 2005;14:71-8.
11. Saxon LA, Bristow MR, Boehmer J, et al. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure COMPANION) Trial. Circulation 2006;114:2766-72.
12. Moss AJ, Greenberg H, Case RB, et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004;110:3760-5.
13. Yao G, Freemantle N, Calvert M, et al. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverterdefibrillator. Eur Heart J 2007;28:42-51.
14. Cleland JGF, Daubert J-C, Erdmann E, et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure (the Cardiac Resynchronization-Heart Failure (CARE-HF) trial extension phase). Eur Heart J 2006;27:1928-32.
15. Cleland JGF, Daubert J-C, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49.
16. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
17. Freemantle N, Tharmanathan P, Calvert MJ, et al. Cardiac resynchronization for patients with heart failure due to left ventricular systolic dysfunction. A systematic review and meta-analysis. Eur J Heart Failure 2006;8:433-40.
18. Richardson M, Freemantle N, Calvert MJ, et al. Predictors and treatment response with cardiac resynchronisation therapy in patients with heart failure characterised by dyssynchrony: a predefined analysis from the CARE-HF Trial. Eur Heart J 2007;28:1827-34.
19. Cleland JGF, Freemantle N, Ghio S, et al. Predicting the long-term effects of cardiac resynchronisation and the early response. A report from CARE-HF (Cardiac Resynchronisation in Heart Failure). Eur Heart J 2006;27(Abstract Suppl).
20. Cleland JGF, Freemantle N, Daubert J-C, et al. Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: a report from the CARE-HF Study. Heart 2008;94:278-83.
21. Lin G, Rea RF, Hammill SC, et al. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices. Heart 2008;94:185-90.
22. Thackray SD, Witte KKA, Nikitin NP, et al. The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional pacemaker population. Eur Heart J 2003;24:1143- 52.
23. Curtis AB, Adamson PB, Chung E, et al. Biventricular versus right ventricular pacing in patients with AV block (BLOCK HF): clinical study design and rationale. J Cardiovasc Electrophysiol 2007;18:965-71.
24. Thackray SD, Ghosh J, Wright GA, et al. The effect of altering heart rate on ventricular function in patients with heart failure treated with beta-blockers. Am Heart J 2006;152:713-e9.
25. Goldenberg I, Moss AJ, Hall WJ, et al. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II. Circulation 2006;113:2810-7.
26. Shamim W, Yousufuddin M, Cicoria M, et al. Incremental changes in QRS duration in serial ECGs over time identify high risk elderly patients with heart failure. Heart 2002;88:47-52.